FI864991A0 - Expression och diagnostisk anvaendning av peptider kodade av gag-region vilka peptider aer immunologiskt reaktiva med antikroppar av lav-virus. - Google Patents
Expression och diagnostisk anvaendning av peptider kodade av gag-region vilka peptider aer immunologiskt reaktiva med antikroppar av lav-virus.Info
- Publication number
- FI864991A0 FI864991A0 FI864991A FI864991A FI864991A0 FI 864991 A0 FI864991 A0 FI 864991A0 FI 864991 A FI864991 A FI 864991A FI 864991 A FI864991 A FI 864991A FI 864991 A0 FI864991 A0 FI 864991A0
- Authority
- FI
- Finland
- Prior art keywords
- peptider
- gag
- lav
- expression
- immunologically reactive
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 2
- 101710177291 Gag polyprotein Proteins 0.000 abstract 3
- 101710125418 Major capsid protein Proteins 0.000 abstract 3
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72123785A | 1985-04-08 | 1985-04-08 | |
US75376985A | 1985-07-10 | 1985-07-10 | |
US76346085A | 1985-08-07 | 1985-08-07 | |
US82882886A | 1986-02-12 | 1986-02-12 | |
PCT/US1986/000716 WO1986006099A1 (en) | 1985-04-08 | 1986-04-07 | EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV |
Publications (2)
Publication Number | Publication Date |
---|---|
FI864991A FI864991A (fi) | 1986-12-08 |
FI864991A0 true FI864991A0 (fi) | 1986-12-08 |
Family
ID=27505554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI864991A FI864991A0 (fi) | 1985-04-08 | 1986-12-08 | Expression och diagnostisk anvaendning av peptider kodade av gag-region vilka peptider aer immunologiskt reaktiva med antikroppar av lav-virus. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0220234B1 (fi) |
JP (1) | JP3095219B2 (fi) |
AT (1) | ATE109512T1 (fi) |
AU (1) | AU594333B2 (fi) |
CA (1) | CA1341384C (fi) |
DE (1) | DE3650011T2 (fi) |
ES (1) | ES8706824A1 (fi) |
FI (1) | FI864991A0 (fi) |
GR (1) | GR860915B (fi) |
IE (1) | IE65162B1 (fi) |
WO (1) | WO1986006099A1 (fi) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8423659D0 (en) * | 1984-09-19 | 1984-10-24 | Pasteur Institut | Cloned dna sequences |
DE3526995A1 (de) * | 1985-07-27 | 1987-02-05 | Hoechst Ag | Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung |
FR2593519B1 (fr) * | 1985-09-25 | 1994-01-07 | Oncogen | Vaccin contre le syndrome immunodeficitaire acquis et intermediaires pour la preparation de ce vaccin |
ES2054616T3 (es) * | 1985-12-17 | 1994-08-16 | Akzo Nv | Reactivo inmunoquimico. |
DE3674555D1 (de) * | 1985-12-20 | 1990-10-31 | Abbott Lab | Immuntest fuer antikoerper gegen htlv-iii. |
US4808536A (en) * | 1986-02-27 | 1989-02-28 | Centocor, Inc. | Immunochemical method for detection of antibody against HTLV-III core protein based upon recombinant HTLV-III gag gene encoded protein |
US5075211A (en) * | 1986-03-26 | 1991-12-24 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
US4925784A (en) * | 1986-04-04 | 1990-05-15 | Hoffmann-La Roche Inc. | Expression and purification of an HTLV-III gag/env gene protein |
US5166050A (en) * | 1986-08-20 | 1992-11-24 | Bristol-Myers Squibb Company | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections |
NZ221440A (en) * | 1986-08-20 | 1991-11-26 | Genetic Systems Corp | Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections |
FR2607518B1 (fr) * | 1986-12-01 | 1989-10-20 | Transgene Sa | Vecteur viral et adn recombinant codant pour la proteine p25 du virus agent causal du s.i.d.a., culture cellulaire infectee, proteine obtenue, vaccin et anticorps obtenus |
CA1339363C (en) * | 1987-05-01 | 1997-08-26 | Alan Ray Flesher | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
US5256767A (en) * | 1987-06-10 | 1993-10-26 | The Immune Response Corporation | Retroviral antigens |
EP0685236A1 (en) * | 1987-06-10 | 1995-12-06 | The Immune Response Corporation, Inc. | Prevention and treatment of retroviral disease |
DK643188A (da) * | 1987-11-24 | 1989-05-25 | Smithkline Biolog | Ekspression af hiv-proteiner i e.coli og s.cerevisiae |
SE468168B (sv) * | 1990-02-20 | 1992-11-16 | Replico Medical Ab | Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8423659D0 (en) * | 1984-09-19 | 1984-10-24 | Pasteur Institut | Cloned dna sequences |
US4520113A (en) * | 1984-04-23 | 1985-05-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions |
GB8501473D0 (en) * | 1985-01-21 | 1985-02-20 | Pasteur Institut | Cloned dna sequences |
CA1341482C (en) * | 1984-10-31 | 2005-05-10 | Paul A. Luciw | Process for preparing fragments of aids-associated retroviruses |
AU600658B2 (en) * | 1984-12-24 | 1990-08-23 | Genentech Inc. | Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use |
GR862412B (en) * | 1985-09-25 | 1987-01-23 | Oncogen | Vaccines and immuinoassays for acquired immune deficiency syndrome |
AU6713287A (en) * | 1986-01-06 | 1987-07-09 | F. Hoffmann-La Roche & Co. | Expression of htlv-iii gag-gene |
US4808536A (en) * | 1986-02-27 | 1989-02-28 | Centocor, Inc. | Immunochemical method for detection of antibody against HTLV-III core protein based upon recombinant HTLV-III gag gene encoded protein |
-
1986
- 1986-04-07 GR GR860915A patent/GR860915B/el unknown
- 1986-04-07 AU AU56690/86A patent/AU594333B2/en not_active Expired
- 1986-04-07 ES ES553758A patent/ES8706824A1/es not_active Expired
- 1986-04-07 WO PCT/US1986/000716 patent/WO1986006099A1/en active IP Right Grant
- 1986-04-07 DE DE3650011T patent/DE3650011T2/de not_active Expired - Lifetime
- 1986-04-07 EP EP86902680A patent/EP0220234B1/en not_active Expired - Lifetime
- 1986-04-07 AT AT86902680T patent/ATE109512T1/de not_active IP Right Cessation
- 1986-04-07 CA CA000506020A patent/CA1341384C/en not_active Expired - Lifetime
- 1986-04-08 IE IE91286A patent/IE65162B1/en not_active IP Right Cessation
- 1986-12-08 FI FI864991A patent/FI864991A0/fi not_active IP Right Cessation
-
1998
- 1998-08-17 JP JP10230393A patent/JP3095219B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES8706824A1 (es) | 1987-07-01 |
FI864991A (fi) | 1986-12-08 |
IE860912L (en) | 1986-10-08 |
DE3650011T2 (de) | 1994-11-17 |
EP0220234B1 (en) | 1994-08-03 |
DE3650011D1 (de) | 1994-09-08 |
IE65162B1 (en) | 1995-10-04 |
AU5669086A (en) | 1986-11-05 |
EP0220234A4 (en) | 1988-11-09 |
AU594333B2 (en) | 1990-03-08 |
JPH11127856A (ja) | 1999-05-18 |
JP3095219B2 (ja) | 2000-10-03 |
GR860915B (en) | 1986-07-11 |
CA1341384C (en) | 2002-08-20 |
WO1986006099A1 (en) | 1986-10-23 |
ATE109512T1 (de) | 1994-08-15 |
ES553758A0 (es) | 1987-07-01 |
EP0220234A1 (en) | 1987-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI864991A (fi) | Expression och diagnostisk anvaendning av peptider kodade av gag-region vilka peptider aer immunologiskt reaktiva med antikroppar av lav-virus. | |
SE8701413D0 (sv) | Expression and purification of an htlv-iii gag/env gene protein | |
DK0942983T3 (da) | Streptococcus pneumoniae-antigener og -vacciner | |
UA42668C2 (uk) | Поліпептид, що має антигенні властивості вірусу гепатиту с (hcv) (варіанти), діагностичний реагент для виявлення антитіл до вірусу гепатиту с (варіанти), набір для виявлення антитіл до вірусу гепатиту с (варіанти), спосіб виявлення антитіл до вірусу гепатиту с (варіанти) | |
FI861626A (fi) | Foervaervat immunbristsyndrom (aids) -relaterat viralt rekombinant hoeljeprotein samt ett testfoerfarande foer aids. | |
AU571128B2 (en) | Expression of immunologically reactive aids viral protein | |
EP0476130A4 (en) | Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof | |
NO175153C (no) | Polypeptider | |
OA09643A (en) | Procedure to abtain a test method for african swine fever virus (ASFV) and product directly obtained by the same | |
FI870501A0 (fi) | Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut | |
DK589586A (da) | Ekspression og diagnostisk anvendelse af gag-kodede peptider, der er immunologisk reaktive med antistoffer til lav. | |
Phillips et al. | Physical and morphological characteristics of eucaryotic ribosomes and lipopolysaccharide complexes | |
ES8801959A1 (es) | Un procedimiento para ensayos de sangre humana respecto de la presencia de anticuerpos frente al agente etiologico viral de sida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
MM | Patent lapsed |
Owner name: GENETIC SYSTEMS CORPORATION |